Arcus Biosciences (RCUS) Technical (Analysis) Reports Arcus Biosciences ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arcus Biosciences (RCUS)
Technical Analysis Report for NYSE stock RCUS Arcus Biosciences. Dated: 09 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock RCUS Arcus Biosciences then click here. or read Experts views on Arcus Biosciences or Forecast & share price targets of Arcus Biosciences
Arcus Biosciences Opened at 21.06 and Closed at: 21.13, which is 0.47% of previous session's close. It moved within a range of 20.44 and 21.23
The session was a Bullish session with an average volume of 569400, which is -46.31% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 4 days back on short term averages
A Golden cross was found 6 days back on short term averages
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 20.79 and resistance for tomorrow is 21.58
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 20.64, 20.14 resistance for tomorrow's hourly charts is 21.43, 21.72
10 Day SMA for Arcus Biosciences (RCUS) is 21.43 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arcus Biosciences (RCUS) is 21.95 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arcus Biosciences (RCUS) is 22.94 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 19.93 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Arcus Biosciences is 14.64 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arcus Biosciences is at 21.95 and 200 DMA is at 14.64, while 50 DMA and 100 DMA are at 22.94 and 19.93 respectively
Arcus Biosciences (RCUS) moving average of 20 SMA is at 21.95 and 20 EMA is at 21.74
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Mon Feb | 21.13 | 21.95 | 21.74 |
| 06 Fri Feb | 21.03 | 21.95 | 21.8 |
| 05 Thu Feb | 20.03 | 21.96 | 21.88 |
| 04 Wed Feb | 20.99 | 22.12 | 22.08 |
| 03 Tue Feb | 21.96 | 22.16 | 22.2 |
| 02 Mon Feb | 21.66 | 22.15 | 22.23 |
Arcus Biosciences (RCUS) moving average of 50 SMA is at 22.94 and 50 EMA is at 21.68
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Mon Feb | 21.13 | 22.94 | 21.68 |
| 06 Fri Feb | 21.03 | 23 | 21.7 |
| 05 Thu Feb | 20.03 | 23.04 | 21.73 |
| 04 Wed Feb | 20.99 | 23.08 | 21.8 |
| 03 Tue Feb | 21.96 | 23.09 | 21.83 |
| 02 Mon Feb | 21.66 | 23.05 | 21.82 |
Arcus Biosciences (RCUS) moving average of 100 SMA is at 19.93 and 100 EMA is at 19.81
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Mon Feb | 21.13 | 19.93 | 19.81 |
| 06 Fri Feb | 21.03 | 19.83 | 19.78 |
| 05 Thu Feb | 20.03 | 19.74 | 19.75 |
| 04 Wed Feb | 20.99 | 19.65 | 19.74 |
| 03 Tue Feb | 21.96 | 19.56 | 19.71 |
| 02 Mon Feb | 21.66 | 19.46 | 19.66 |
Arcus Biosciences (RCUS) moving average of 200 SMA is at 14.64 and 200 EMA is at 17.25
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Mon Feb | 21.13 | 14.64 | 17.25 |
| 06 Fri Feb | 21.03 | 14.57 | 17.21 |
| 05 Thu Feb | 20.03 | 14.51 | 17.17 |
| 04 Wed Feb | 20.99 | 14.45 | 17.14 |
| 03 Tue Feb | 21.96 | 14.38 | 17.1 |
| 02 Mon Feb | 21.66 | 14.31 | 17.05 |
Smith Nephew has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Smith Nephew, about 4.9% more returns!
Select Medical has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Select Medical, about 4.03% more returns!
Abbvie Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Abbvie Inc, about 2.26% more returns!
Becton Dickinson has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Becton Dickinson, about 3.09% more returns!
Brookdale Senior has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Brookdale Senior, about 48% more returns!
Bristol Myers has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Bristol Myers, about 9.75% more returns!
Arcus Biosciences has performed better than Charles River in short term. Holding Arcus Biosciences could be a better choice for now!
Arcus Biosciences has performed better than Cvs Health in short term. Holding Arcus Biosciences could be a better choice for now!
Davita Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Davita Inc, about 25.81% more returns!
Glaxosmithkline Plc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 17.93% more returns!
Herbalife Nutrition has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Herbalife Nutrition, about 8.64% more returns!
Johnson Johnson has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Johnson Johnson, about 14.58% more returns!
Laboratory Corporation has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Laboratory Corporation, about 10.23% more returns!
Medtronic Plc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Medtronic Plc, about 5.68% more returns!
Merck Company has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Merck Company, about 8.52% more returns!
Arcus Biosciences has performed better than Nu Skin in short term. Holding Arcus Biosciences could be a better choice for now!
Novartis Ag has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Novartis Ag, about 11.54% more returns!
Penumbra Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Penumbra Inc, about 6.93% more returns!
Qiagen N has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Qiagen N, about 8.27% more returns!
Arcus Biosciences Technical analysis of indicators
Price action analysis of Arcus Biosciences (RCUS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arcus Biosciences stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Arcus Biosciences in short term and the sell signal is strong.
Arcus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arcus Biosciences in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arcus Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.42 and Arcus Biosciences RCUS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arcus Biosciences RCUS stock. Volume based technical analysis of Arcus Biosciences RCUS stock is negative.
Arcus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock RCUS Arcus Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And RCUS Experts View which covers a lot of information including buying and selling signals
RCUS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arcus Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arcus Biosciences (RCUS) Technical (Analysis) Reports Arcus Biosciences ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


